您的当前位置:首页 > 行业数据 > ONC-392与传统CTLA-4单抗对比(机制、疗效、安全性)
图片属性
图片格式:PNG 图片大小:725KB 图片尺寸:2302*1054
同报告图片
 / 4
ONC-392与传统CTLA-4单抗对比(机制、疗效、安全性)_第1页
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
ONC-392与传统CTLA-4单抗对比(机制、疗效、安全性)_第2页
ONC-392与传统CTLA-4单抗对比(机制、疗效、安全性)_第3页
ONC-392与传统CTLA-4单抗对比(机制、疗效、安全性)_第4页
ONC-392与传统CTLA-4单抗对比(机制、疗效、安全性)_第5页
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
所属报告: 医药生物行业CTLA4专题:技术革新来临聚焦“增效减毒”的新一代疗法投资机遇-251222(18页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠